Extrapituitary prolactin: distribution, regulation, functions, and clinical aspects

N Ben-Jonathan, JL Mershon, DL Allen… - Endocrine …, 1996 - academic.oup.com
D. Mammary and milk PRL IV. PRL and the Immune System A. Production of PRL by
immune cells B. PRL receptors in immune cells C. Immunoregulatory functions of PRL V …

The role of prolactin in mammary carcinoma

CV Clevenger, PA Furth, SE Hankinson… - Endocrine …, 2003 - academic.oup.com
The contribution of prolactin (PRL) to the pathogenesis and progression of human breast
cancer at the cellular, transgenic, and epidemiological levels is increasingly appreciated …

Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse.

CJ Ormandy, A Camus, J Barra, D Damotte… - Genes & …, 1997 - genesdev.cshlp.org
Mice carrying a germ-line null mutation of the prolactin receptor gene have been produced
by gene targeting in embryonic stem cells. Heterozygous females showed almost complete …

The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation

L De Petrocellis, D Melck… - Proceedings of the …, 1998 - National Acad Sciences
Anandamide was the first brain metabolite shown to act as a ligand of “central” CB1
cannabinoid receptors. Here we report that the endogenous cannabinoid potently and …

c-Myc in breast cancer.

DJ Liao, RB Dickson - Endocrine-related cancer, 2000 - erc.bioscientifica.com
Ever since Bishop and his co-workers discovered the c-myc gene in the late 1970s (Bishop
1982), voluminous literature has documented its central role in proliferation and malignant …

Xenoestrogens at Picomolar to Nanomolar Concentrations Trigger Membrane Estrogen Receptor-α–Mediated Ca2+ Fluxes and Prolactin Release in GH3/B6 …

AL Wozniak, NN Bulayeva… - Environmental health …, 2005 - ehp.niehs.nih.gov
Xenoestrogens (XEs) are widespread in our environment and are known to have deleterious
effects in animal (and perhaps human) populations. Acting as inappropriate estrogens, XEs …

Osteoporosis, genetics and hormones

R Rizzoli, JP Bonjour, SL Ferrari - Journal of molecular …, 2001 - jme.bioscientifica.com
Currently, there is no completely effective therapy available for metastatic
phaeochromocytomas (PCCs) and paragangliomas. In this study, we explore new molecular …

Minireview: new roles for peripheral dopamine on metabolic control and tumor growth: let's seek the balance

B Rubí, P Maechler - Endocrinology, 2010 - academic.oup.com
In peripheral tissues, dopamine is released from neuronal cells and is synthesized within
specific parenchyma. Dopamine released from sympathetic nerves predominantly …

[PDF][PDF] Position statement for clinical practice: prolactin-secreting tumors

R Cozzi, MR Ambrosio, R Attanasio… - European Journal of …, 2022 - research.unipd.it
Prolactinomas are the most frequent pituitary adenomas. Prolactinoma may occur in different
clinical settings and always require an individually tailored approach. This is the reason why …

Plasma prolactin levels and subsequent risk of breast cancer in postmenopausal women

SE Hankinson, WC Willett, DS Michaud… - Journal of the …, 1999 - academic.oup.com
BACKGROUND: In animal studies, prolactin has been found to be important for mammary
epithelial development and its administration has been shown consistently to increase the …